Sitrin Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Sitrin Capital Management's LLY Position: Q3 2026 in Review
Sitrin Capital Management reduced its Eli Lilly (LLY) stake by 1.3% in Q3 2026, selling an estimated $94.4K and leaving 5,864 shares worth $6.79M. The position accounts for 3.06% of the portfolio, ranked #17.
Sitrin Capital Management first reported a position in LLY in Q2 2024 and has held it in 10 quarters since. The position peaked at $7.13M in Q2 2026. 2,091 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Sitrin Capital Management held 5,864 shares of Eli Lilly worth $6.79M as of Q3 2026.
- Sitrin Capital Management sold 80 Eli Lilly shares in Q3 2026, an estimated $94.4K.
- Eli Lilly made up 3.06% of Sitrin Capital Management's portfolio in Q3 2026, its #17 holding.
- Sitrin Capital Management first reported a position in Eli Lilly in Q2 2024 and has held it in 10 quarters since.
- Sitrin Capital Management's Eli Lilly position peaked at $7.13M in Q2 2026.
- 2,091 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Sitrin Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.